HomeMARKSANS • NSE
add
Marksans Pharma Ltd
Previous close
₹337.50
Day range
₹338.40 - ₹351.50
Year range
₹130.00 - ₹351.50
Market cap
156.52B INR
Avg Volume
2.26M
P/E ratio
45.15
Dividend yield
0.17%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 6.42B | 20.84% |
Operating expense | 2.67B | 46.80% |
Net income | 967.16M | 15.80% |
Net profit margin | 15.07 | -4.13% |
Earnings per share | — | — |
EBITDA | 1.36B | 21.56% |
Effective tax rate | 21.54% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.72B | 1.65% |
Total assets | 29.11B | 25.84% |
Total liabilities | 6.06B | 45.52% |
Total equity | 23.05B | — |
Shares outstanding | 454.07M | — |
Price to book | 6.72 | — |
Return on assets | — | — |
Return on capital | 12.02% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 967.16M | 15.80% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1992
Website
Employees
1,141
